US Stock MarketDetailed Quotes

ELVN Enliven Therapeutics

Watchlist
  • 21.080
  • +0.160+0.76%
Close Mar 21 16:00 ET
  • 22.455
  • +1.375+6.52%
Post 20:01 ET
1.03BMarket Cap-11.15P/E (TTM)

Enliven Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-19.46%-73.19M
-37.82%-17.2M
23.29%-12.19M
-69.60%-20.44M
-12.08%-23.36M
-91.01%-61.27M
-53.25%-12.48M
-146.53%-15.89M
-69.13%-12.05M
-101.18%-20.84M
Net income from continuing operations
-24.36%-89.02M
-19.67%-23.18M
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-90.07%-71.58M
-102.83%-19.37M
-96.79%-20.77M
-88.11%-16.72M
-69.85%-14.72M
Operating gains losses
--11K
----
----
----
----
----
----
----
----
----
Depreciation and amortization
6.73%317K
2.56%80K
2.56%80K
5.41%78K
17.91%79K
38.14%297K
21.88%78K
30.00%78K
42.31%74K
71.79%67K
Other non cash items
-280.72%-553K
3.85%81K
--7K
---720K
--79K
--306K
--78K
----
----
----
Change In working capital
-424.13%-4.54M
-109.33%-510K
58.25%4.99M
-455.27%-4.38M
45.14%-4.64M
219.86%1.4M
801.65%5.46M
161.58%3.15M
21.94%1.23M
-254.26%-8.45M
-Change in prepaid assets
-28.76%-4.77M
-68.87%536K
132.34%783K
-850.00%-2.45M
40.18%-3.64M
-132.89%-3.7M
2,365.79%1.72M
162.18%337K
175.81%326K
-1,023.25%-6.09M
-Change in payables and accrued expense
-89.62%562K
-125.15%-961K
40.90%4.29M
-304.18%-1.86M
61.44%-910K
167.49%5.41M
461.09%3.82M
74.44%3.04M
-36.92%909K
-28.05%-2.36M
-Change in other current liabilities
-8.06%-335K
-7.59%-85K
63.32%-84K
-8,200.00%-83K
-8,200.00%-83K
-7,850.00%-310K
-8,000.00%-79K
---229K
---1K
---1K
Cash from discontinued investing activities
Operating cash flow
-19.46%-73.19M
-37.82%-17.2M
23.29%-12.19M
-69.60%-20.44M
-12.08%-23.36M
-91.01%-61.27M
-53.25%-12.48M
-146.53%-15.89M
-69.13%-12.05M
-101.18%-20.84M
Investing cash flow
Cash flow from continuing investing activities
75.75%-36M
-98.12%727K
141.71%14.83M
77.78%-33.67M
-57,593.55%-17.89M
-24,150.33%-148.41M
38,402.97%38.69M
-253,821.43%-35.55M
-49,905.94%-151.52M
84.02%-31K
Net PPE purchase and sale
70.47%-44K
--0
-37.50%-22K
97.73%-2K
35.48%-20K
75.65%-149K
86.14%-14K
-14.29%-16K
70.96%-88K
84.02%-31K
Net investment purchase and sale
75.16%-36.83M
-98.12%727K
167.47%23.98M
71.17%-43.66M
---17.87M
---148.26M
--38.7M
---35.53M
---151.43M
--0
Net other investing changes
--873K
--0
---9.13M
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
75.75%-36M
-98.12%727K
141.71%14.83M
77.78%-33.67M
-57,593.55%-17.89M
-24,150.33%-148.41M
38,402.97%38.69M
-253,821.43%-35.55M
-49,905.94%-151.52M
84.02%-31K
Financing cash flow
Cash flow from continuing financing activities
-43.16%133.17M
44,313.33%39.97M
362.82%1.12M
164.04%1.81M
-61.98%90.27M
13,123.12%234.29M
103.79%90K
-359.15%-425K
-56,500.00%-2.82M
57,954.03%237.44M
Net common stock issuance
--39.19M
---50.51M
--0
---305K
--90M
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
23,453.13%93.98M
100,432.22%90.48M
3,889.29%1.12M
1,397.16%2.11M
92.86%270K
-32.49%399K
592.31%90K
--28K
2,720.00%141K
-75.57%140K
Net other financing activities
----
----
----
----
----
9,886.07%233.89M
--0
---453K
---2.96M
144,795.73%237.3M
Cash from discontinued financing activities
Financing cash flow
-43.16%133.17M
44,313.33%39.97M
362.82%1.12M
164.04%1.81M
-61.98%90.27M
13,123.12%234.29M
103.79%90K
-359.15%-425K
-56,500.00%-2.82M
57,954.03%237.44M
Net cash flow
Beginning cash position
32.55%100.2M
36.23%100.68M
-22.93%96.93M
-48.92%149.22M
32.55%100.2M
-31.33%75.59M
-14.28%73.9M
35.95%125.77M
192.35%292.16M
-31.33%75.59M
Current changes in cash
-2.56%23.98M
-10.64%23.5M
107.23%3.75M
68.57%-52.29M
-77.36%49.02M
171.34%24.61M
347.52%26.29M
-723.69%-51.87M
-2,141.81%-166.39M
2,234.50%216.57M
End cash Position
23.93%124.17M
23.93%124.17M
36.23%100.68M
-22.93%96.93M
-48.92%149.22M
32.55%100.2M
32.55%100.2M
-14.28%73.9M
35.95%125.77M
192.35%292.16M
Free cash flow
-19.24%-73.24M
-37.67%-17.2M
23.22%-12.22M
-68.39%-20.44M
-12.00%-23.38M
-87.89%-61.42M
-51.54%-12.5M
-146.25%-15.91M
-63.42%-12.14M
-97.77%-20.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -19.46%-73.19M-37.82%-17.2M23.29%-12.19M-69.60%-20.44M-12.08%-23.36M-91.01%-61.27M-53.25%-12.48M-146.53%-15.89M-69.13%-12.05M-101.18%-20.84M
Net income from continuing operations -24.36%-89.02M-19.67%-23.18M-11.49%-23.16M-19.31%-19.95M-54.43%-22.74M-90.07%-71.58M-102.83%-19.37M-96.79%-20.77M-88.11%-16.72M-69.85%-14.72M
Operating gains losses --11K------------------------------------
Depreciation and amortization 6.73%317K2.56%80K2.56%80K5.41%78K17.91%79K38.14%297K21.88%78K30.00%78K42.31%74K71.79%67K
Other non cash items -280.72%-553K3.85%81K--7K---720K--79K--306K--78K------------
Change In working capital -424.13%-4.54M-109.33%-510K58.25%4.99M-455.27%-4.38M45.14%-4.64M219.86%1.4M801.65%5.46M161.58%3.15M21.94%1.23M-254.26%-8.45M
-Change in prepaid assets -28.76%-4.77M-68.87%536K132.34%783K-850.00%-2.45M40.18%-3.64M-132.89%-3.7M2,365.79%1.72M162.18%337K175.81%326K-1,023.25%-6.09M
-Change in payables and accrued expense -89.62%562K-125.15%-961K40.90%4.29M-304.18%-1.86M61.44%-910K167.49%5.41M461.09%3.82M74.44%3.04M-36.92%909K-28.05%-2.36M
-Change in other current liabilities -8.06%-335K-7.59%-85K63.32%-84K-8,200.00%-83K-8,200.00%-83K-7,850.00%-310K-8,000.00%-79K---229K---1K---1K
Cash from discontinued investing activities
Operating cash flow -19.46%-73.19M-37.82%-17.2M23.29%-12.19M-69.60%-20.44M-12.08%-23.36M-91.01%-61.27M-53.25%-12.48M-146.53%-15.89M-69.13%-12.05M-101.18%-20.84M
Investing cash flow
Cash flow from continuing investing activities 75.75%-36M-98.12%727K141.71%14.83M77.78%-33.67M-57,593.55%-17.89M-24,150.33%-148.41M38,402.97%38.69M-253,821.43%-35.55M-49,905.94%-151.52M84.02%-31K
Net PPE purchase and sale 70.47%-44K--0-37.50%-22K97.73%-2K35.48%-20K75.65%-149K86.14%-14K-14.29%-16K70.96%-88K84.02%-31K
Net investment purchase and sale 75.16%-36.83M-98.12%727K167.47%23.98M71.17%-43.66M---17.87M---148.26M--38.7M---35.53M---151.43M--0
Net other investing changes --873K--0---9.13M----------------------------
Cash from discontinued investing activities
Investing cash flow 75.75%-36M-98.12%727K141.71%14.83M77.78%-33.67M-57,593.55%-17.89M-24,150.33%-148.41M38,402.97%38.69M-253,821.43%-35.55M-49,905.94%-151.52M84.02%-31K
Financing cash flow
Cash flow from continuing financing activities -43.16%133.17M44,313.33%39.97M362.82%1.12M164.04%1.81M-61.98%90.27M13,123.12%234.29M103.79%90K-359.15%-425K-56,500.00%-2.82M57,954.03%237.44M
Net common stock issuance --39.19M---50.51M--0---305K--90M--0--0--0--0--0
Proceeds from stock option exercised by employees 23,453.13%93.98M100,432.22%90.48M3,889.29%1.12M1,397.16%2.11M92.86%270K-32.49%399K592.31%90K--28K2,720.00%141K-75.57%140K
Net other financing activities --------------------9,886.07%233.89M--0---453K---2.96M144,795.73%237.3M
Cash from discontinued financing activities
Financing cash flow -43.16%133.17M44,313.33%39.97M362.82%1.12M164.04%1.81M-61.98%90.27M13,123.12%234.29M103.79%90K-359.15%-425K-56,500.00%-2.82M57,954.03%237.44M
Net cash flow
Beginning cash position 32.55%100.2M36.23%100.68M-22.93%96.93M-48.92%149.22M32.55%100.2M-31.33%75.59M-14.28%73.9M35.95%125.77M192.35%292.16M-31.33%75.59M
Current changes in cash -2.56%23.98M-10.64%23.5M107.23%3.75M68.57%-52.29M-77.36%49.02M171.34%24.61M347.52%26.29M-723.69%-51.87M-2,141.81%-166.39M2,234.50%216.57M
End cash Position 23.93%124.17M23.93%124.17M36.23%100.68M-22.93%96.93M-48.92%149.22M32.55%100.2M32.55%100.2M-14.28%73.9M35.95%125.77M192.35%292.16M
Free cash flow -19.24%-73.24M-37.67%-17.2M23.22%-12.22M-68.39%-20.44M-12.00%-23.38M-87.89%-61.42M-51.54%-12.5M-146.25%-15.91M-63.42%-12.14M-97.77%-20.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+5.27%
Apple
AAPL
+1.95%
Meta Platforms
META
+1.75%
Microsoft
MSFT
+1.14%
Petroleo Brasileiro SA Petrobras
PBR
+0.93%

Unlock the Full List